Caption Management’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.67M | Buy |
31,338
+26,738
| +581% | +$1.43M | 0.02% | 168 |
|
|
2025
Q1 | $186K | Buy |
+4,600
| New | +$186K | ﹤0.01% | 399 |
|
|
2024
Q4 | – | Sell |
-10,087
| Closed | -$289K | – | 527 |
|
|
2024
Q3 | $289K | Buy |
+10,087
| New | +$289K | ﹤0.01% | 283 |
|
|
2024
Q2 | – | Sell |
-10,269
| Closed | -$259K | – | 406 |
|
|
2024
Q1 | $259K | Buy |
10,269
+9,738
| +1,834% | +$246K | ﹤0.01% | 258 |
|
|
2023
Q4 | $12.4K | Sell |
531
-734
| -58% | -$17.1K | ﹤0.01% | 412 |
|
|
2023
Q3 | $64K | Sell |
1,265
-10,835
| -90% | -$548K | ﹤0.01% | 363 |
|
|
2023
Q2 | $565K | Sell |
12,100
-10,060
| -45% | -$470K | 0.01% | 180 |
|
|
2023
Q1 | $848K | Buy |
22,160
+17,060
| +335% | +$653K | 0.02% | 134 |
|
|
2022
Q4 | $279K | Buy |
+5,100
| New | +$279K | ﹤0.01% | 265 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 516 |
|
|
2020
Q2 | – | Sell |
-900
| Closed | -$19K | – | 308 |
|
|
2020
Q1 | $19K | Buy |
+900
| New | +$19K | ﹤0.01% | 294 |
|